Compass Pathways grants options to CMO Goodwin

Compass Pathways plc reported that Chief Medical Officer Guy Goodwin received two new stock option awards.

Rhea-AI Filing Summary

Compass Pathways plc reported that Chief Medical Officer Guy Goodwin received two new stock option awards. He was granted options over 55,000 ordinary shares at an exercise price of 0.01 per share and options over 115,600 ordinary shares at an exercise price of 5.64 per share.

The 55,000-share nominal cost option vests in four equal annual installments beginning on March 26, 2027. The 115,600-share option vests in 48 equal monthly installments beginning on April 26, 2026. Each ordinary share may be represented by one American Depositary Share. No open-market purchases or sales were reported in this filing.

Insider Trade Summary

Grant/Award: 170,600 shares

Grant/Award 2 txns

Insider Goodwin Guy

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Share Option (Right to Buy)	55,000	$0.00	$0.00
Grant/Award	Share Option (Right to Buy)	115,600	$0.00	$0.00

Holdings After Transaction: Share Option (Right to Buy) — 170,600 contracts (Direct)

Footnotes (3)

1. F1. The nominal cost share option shall vest in four equal annual installments beginning on March 26, 2027.
2. F2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
3. F3. This Option shall vest in forty-eight equal monthly installments beginning on April 26, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did COMPASS Pathways (CMPS) report for Guy Goodwin?

COMPASS Pathways reported that Chief Medical Officer Guy Goodwin received two stock option grants. He was awarded options over 55,000 ordinary shares and 115,600 ordinary shares as part of compensation, with no open-market share purchases or sales disclosed in this filing.

How many COMPASS Pathways (CMPS) options were granted to the CMO?

Guy Goodwin received options over a total of 170,600 COMPASS Pathways ordinary shares. One grant covers 55,000 shares at a nominal 0.01 exercise price, and another covers 115,600 shares at a 5.64 exercise price, both vesting over multi-year schedules.

What are the vesting terms of the new CMPS option grants?

The 55,000-share option vests in four equal annual installments starting March 26, 2027. The 115,600-share option vests in 48 equal monthly installments beginning April 26, 2026. These schedules spread Guy Goodwin’s potential share ownership over several years, aligning with continued service.

Did the CMPS Form 4 show any insider share sales or purchases?

The Form 4 for COMPASS Pathways shows only stock option awards to Chief Medical Officer Guy Goodwin. It reports no open-market purchases or sales of ordinary shares, indicating the activity is compensation-related rather than trading in existing equity holdings.

How do COMPASS Pathways (CMPS) options relate to American Depositary Shares?

The filing notes that each COMPASS Pathways ordinary share may be represented by one American Depositary Share. This means the reported option grants over ordinary shares correspond one-for-one with potential ADS, simplifying how U.S. investors view the underlying equity exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/27/2026 - 09:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goodwin Guy

(Last) (First) (Middle)

COMPASS PATHWAYS PLC

33 BROADWICK STREET

(Street)

LONDON W1F 0DQ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
COMPASS Pathways plc [ CMPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (Right to Buy)	$0.01	03/26/2026		A		55,000		03/26/2027(1)	03/25/2036	Ordinary Shares(2)	55,000	$0	55,000	D
Share Option (Right to Buy)	$5.64	03/26/2026		A		115,600		04/26/2026(3)	03/25/2036	Ordinary Shares(2)	115,600	$0	115,600	D

Explanation of Responses:

1. The nominal cost share option shall vest in four equal annual installments beginning on March 26, 2027.

2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

3. This Option shall vest in forty-eight equal monthly installments beginning on April 26, 2026.

Remarks:

	/s/ Meredith Prithviraj by Power of Attorney for Guy Goodwin	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)